Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin
- PMID: 12561248
Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin
Abstract
The purpose of this investigation was to study the feasibility of transdermal delivery of glibenclamide and glipizide. In vitro permeation of these drugs was studied through mouse skin using various penetration enhancers like Tween -20, polyethyleneglycol-400, ethanol and d-limonene by simultaneous application of drug and enhancer solution or by pretreatment of the skin with neat enhancer. The partition coefficient values indicated that both drugs partition well into the skin. Glipizide did not show any skin metabolism, while glibenclamide showed a minimal metabolism during in vitro skin metabolism studies. The flux values (microgram/cm2/h) of both drugs significantly (p < 0.05) increased in the presence of penetration enhancers. The glibenclamide flux values ranged from 1.39 +/- 0.13 without enhancer, to 19.01 +/- 2.14 in a combination of 50% ethanol and 5% d-limonene. Glipizide flux values ranged from 3.01 +/- 0.74 without enhancer, to 62.97 +/- 7.10 in a combination of 50% ethanol and 5% d-limonene. Skin retention and solubility of both drugs increased with all penetration enhancers compared to control. The target permeation rates for glibenclamide and glipizide were calculated to be 193.8 and 184.8 micrograms/h respectively. The present study showed that the target permeation rates for both drugs could be achieved with the aid of enhancers by increasing the area of application in an appreciable range.
Similar articles
-
Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin.Pharmazie. 2003 Dec;58(12):891-4. Pharmazie. 2003. PMID: 14703968
-
Passive and iontophoretic permeation of glipizide.Eur J Pharm Biopharm. 2008 Aug;69(3):958-63. doi: 10.1016/j.ejpb.2008.01.010. Epub 2008 Jan 19. Eur J Pharm Biopharm. 2008. PMID: 18291633
-
Pharmacological evaluation of membrane-moderated transdermal system of glipizide.Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):17-26. doi: 10.1111/j.1440-1681.2006.04318.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16445694
-
Microemulsions as transdermal drug delivery vehicles.Adv Colloid Interface Sci. 2006 Nov 16;123-126:369-85. doi: 10.1016/j.cis.2006.05.014. Epub 2006 Jul 14. Adv Colloid Interface Sci. 2006. PMID: 16843424 Review.
-
[Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept].Diabetes Metab. 1997 Nov;23 Suppl 4:39-43. Diabetes Metab. 1997. PMID: 9463023 Review. French.
Cited by
-
The enhancing effect of ion-pairing on the skin permeation of glipizide.AAPS PharmSciTech. 2009;10(3):967-76. doi: 10.1208/s12249-009-9283-5. Epub 2009 Jul 28. AAPS PharmSciTech. 2009. PMID: 19636711 Free PMC article.
-
Iontophoresis: a potential emergence of a transdermal drug delivery system.Sci Pharm. 2012 Jan-Mar;80(1):1-28. doi: 10.3797/scipharm.1108-20. Epub 2011 Dec 13. Sci Pharm. 2012. PMID: 22396901 Free PMC article.
-
Microcapsules and transdermal patch: a comparative approach for improved delivery of antidiabetic drug.AAPS PharmSciTech. 2009;10(3):928-34. doi: 10.1208/s12249-009-9289-z. Epub 2009 Jul 23. AAPS PharmSciTech. 2009. PMID: 19629706 Free PMC article.
-
Complex Drug Delivery Systems: Controlling Transdermal Permeation Rates with Multiple Active Pharmaceutical Ingredients.AAPS PharmSciTech. 2020 Jun 4;21(5):165. doi: 10.1208/s12249-020-01682-4. AAPS PharmSciTech. 2020. PMID: 32500420 Free PMC article.
-
Formulation and Evaluation of Transdermal Gel Containing Tacrolimus-Loaded Spanlastics: In Vitro, Ex Vivo and In Vivo Studies.Polymers (Basel). 2022 Apr 9;14(8):1528. doi: 10.3390/polym14081528. Polymers (Basel). 2022. PMID: 35458277 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical